Analysis of the promoters and 5′-UTR of mouse Cd59 genes, and of their functional activity in erythrocytes
Open Access
- 16 March 2006
- journal article
- research article
- Published by Springer Science and Business Media LLC in Genes & Immunity
- Vol. 7 (4), 287-297
- https://doi.org/10.1038/sj.gene.6364296
Abstract
The complement regulatory protein CD59 inhibits formation of the membrane attack complex (MAC), the terminal effector of the complement system. There are two mouse Cd59 genes in mice but only one in humans. In the work reported here we (a) mapped the promoter regions of both mCd59a and mCd59b genes, (b) identified two different promoters for each mCd59 gene, (c) defined a previously unrecognized additional exon 1 in each mCd59 gene, (d) identified that each mCd59 gene expresses two different tissue-specific transcripts that differ in their 5′-UTR, and (e) confirmed the presence of mCd59b mRNA in multiple tissues. At the functional level, comparison of the sensitivity of mCd59ab−/− and mCd59a−/− red blood cells to MAC-mediated lysis revealed that mCd59b protects RBC from MAC-mediated lysis, at least in the setting of mCd59a deficiency. Together these findings indicate that the mCd59 genes may have complex and perhaps different regulatory mechanisms in different tissues.This publication has 24 references indexed in Scilit:
- Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjectsImmunology, 2005
- Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparisonImmunology, 2003
- Deficiency of the Mouse Complement Regulatory Protein mCd59b Results in Spontaneous Hemolytic Anemia with Platelet Activation and Progressive Male InfertilityImmunity, 2003
- The dual pathogenesis of paroxysmal nocturnal hemoglobinuriaCurrent Opinion in Hematology, 1996
- CD59: Its role in complement regulation and potential for therapeutic useImmunotechnology, 1995
- Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injuryNature Medicine, 1995
- Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells.The Journal of Experimental Medicine, 1994
- Inherited Complete Deficiency of 20-Kilodalton Homologous Restriction Factor (CD59) as a Cause of Paroxysmal Nocturnal HemoglobinuriaThe New England Journal of Medicine, 1990
- Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.The Journal of Experimental Medicine, 1990
- A family showing inheritance of the Inab phenotypeTransfusion, 1988